ANI Pharmaceuticals, Inc.
ANIP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$18,522 | $18,779 | -$47,896 | -$42,603 |
| Dep. & Amort. | $67,731 | $59,791 | $59,653 | $47,252 |
| Deferred Tax | -$21,913 | -$11,740 | -$15,253 | -$16,754 |
| Stock-Based Comp. | $29,344 | $20,652 | $14,599 | $10,489 |
| Change in WC | -$11,185 | $24,860 | -$51,300 | -$84 |
| Other Non-Cash | $18,562 | $6,617 | $8,994 | $5,022 |
| Operating Cash Flow | $64,017 | $118,959 | -$31,203 | $3,322 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$16,236 | -$8,868 | -$8,876 | -$2,557 |
| Net Acquisitions | -$401,280 | $0 | -$33 | -$84,494 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $12,797 | -$9,643 | -$6,829 | -$18,432 |
| Investing Cash Flow | -$404,719 | -$18,511 | -$15,738 | -$105,483 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $345,219 | -$3,000 | -$3,000 | $99,022 |
| Stock Issued | $0 | $80,555 | $0 | $69,584 |
| Stock Repurch. | -$10,959 | -$4,987 | -$1,959 | -$890 |
| Dividends Paid | -$1,625 | -$1,625 | -$1,625 | -$190 |
| Other Fin. Act. | -$67,690 | -$3,504 | $1,458 | $27,069 |
| Financing Cash Flow | $264,945 | $67,439 | -$5,126 | $194,595 |
| Forex Effect | -$470 | $0 | $0 | $0 |
| Net Chg. in Cash | -$76,227 | $167,887 | -$52,067 | $92,434 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $221,121 | $53,234 | $105,301 | $12,867 |
| End Cash | $144,894 | $221,121 | $53,234 | $105,301 |
| Free Cash Flow | $47,064 | $100,448 | -$47,658 | -$20,316 |